How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Sell
40
SUCEF Quote, Financials, Valuation and Earnings
Last price:
$26.05
Seasonality move
:
5.43%
Day range:
$26.05 - $26.05
52-week range:
$23.50 - $26.05
Dividend yield:
3.11%
P/E ratio:
12.20x
P/S ratio:
0.59x
P/B ratio:
0.65x
Volume:
--
Avg. volume:
--
1-year change:
10.85%
Market cap:
$858.9M
Revenue:
$1.5B
EPS (TTM):
$2.14
Analysts' Opinion
-
Consensus RatingSumitomo Osaka Cement has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Sumitomo Osaka Cement has an estimated downside of -- from its current price of $26.05.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $26.05.
Fair Value
-
According to the consensus of 0 analysts, Sumitomo Osaka Cement has -- downside to fair value with a price target of -- per share.
SUCEF vs. S&P 500
-
Over the past 5 trading days, Sumitomo Osaka Cement has underperformed the S&P 500 by -2.86% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sumitomo Osaka Cement does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sumitomo Osaka Cement revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Sumitomo Osaka Cement reported revenues of $341.4M.
Earnings Growth
-
Sumitomo Osaka Cement earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Sumitomo Osaka Cement reported earnings per share of $0.13.
Enterprise value:
1.4B
EV / Invested capital:
--
Price / LTM sales:
0.59x
EV / EBIT:
12.79x
EV / Revenue:
0.91x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
5.13x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
12.79x
Gross Profit (TTM):
$321.6M
Return On Assets:
3.01%
Net Income Margin (TTM):
4.88%
Return On Equity:
8.09%
Return On Invested Capital:
3.81%
Operating Margin:
2.38%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $1.6B | $1.5B | $1.5B | $384.5M | $341.4M | |
| Gross Profit | $318.4M | $236.4M | $321.6M | $70.6M | $73.5M | |
| Operating Income | $11.3M | -$38.5M | $56.5M | $925.5K | $8.1M | |
| EBITDA | $64.5M | $35.7M | $107.1M | $41.3M | $13.3M | |
| Diluted EPS | $1.43 | $0.08 | $2.14 | $1.10 | $0.13 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $864.1M | $756.6M | $799.4M | $751.8M | $754M | |
| Total Assets | $3.1B | $2.9B | $2.4B | $2.4B | $2.5B | |
| Current Liabilities | $671.1M | $609M | $709.9M | $638.4M | $666.1M | |
| Total Liabilities | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B | |
| Total Equity | $1.9B | $1.9B | $1.3B | $1.3B | $1.3B | |
| Total Debt | $511.2M | $430.5M | $617M | $626M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2009-03-31 | 2010-03-31 | 2011-03-31 | 2010-03-31 | 2011-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $264.6M | $250.3M | $118.8M | $83.7M | |
| Cash From Investing | -- | -$232M | -$174.8M | -$33M | -$38.4M | |
| Cash From Financing | -- | $19M | -$127.6M | $20.2M | -$67.2M | |
| Free Cash Flow | -- | $264.6M | $250.3M | $118.8M | $83.7M | |
SUCEF
Sector
Market Cap
$858.9M
$18.9M
Price % of 52-Week High
100%
57.66%
Dividend Yield
3.11%
0%
Shareholder Yield
--
1.61%
1-Year Price Total Return
10.85%
-18.53%
Beta (5-Year)
--
1.064
Dividend yield:
3.11%
Annualized payout:
$0.80
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$26.05
200-day SMA
Sell
Level
$26.05
Bollinger Bands (100)
Sell
Level
26.05 - 26.05
Chaikin Money Flow
Buy
Level
2.7K
20-day SMA
Sell
Level
$26.05
Relative Strength Index (RSI14)
Buy
Level
100.00
ADX Line
Neutral
Level
Williams %R
Buy
Level
0
50-day SMA
Sell
Level
$26.05
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
1.8K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.8871)
Buy
CA Score
(Annual)
Level (0.1441)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.3253)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sumitomo Osaka Cement Co Ltd is a producer of cement and cement-related products. The largest operating segment by revenue offers assorted cements, ready-mix concrete, cement-related solidification materials, supply of electrical power, and recycling of raw materials and fuel. Sumitomo Osaka Cement also supplies repairing and reinforcing products for concrete structures, mineral resources, optoelectronics, and advanced materials. Sumitomo's operation is focused on Japan, with nearly all its revenue generated in the Japan area.
Stock Forecast FAQ
In the current month, SUCEF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SUCEF average analyst price target in the past 3 months is --.
-
Where Will Sumitomo Osaka Cement Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sumitomo Osaka Cement share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Sumitomo Osaka Cement?
Analysts are divided on their view about Sumitomo Osaka Cement share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sumitomo Osaka Cement is a Sell and believe this share price will rise from its current level to --.
-
What Is Sumitomo Osaka Cement's Price Target?
The price target for Sumitomo Osaka Cement over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SUCEF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sumitomo Osaka Cement is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SUCEF?
You can purchase shares of Sumitomo Osaka Cement via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sumitomo Osaka Cement shares.
-
What Is The Sumitomo Osaka Cement Share Price Today?
Sumitomo Osaka Cement was last trading at $26.05 per share. This represents the most recent stock quote for Sumitomo Osaka Cement. Yesterday, Sumitomo Osaka Cement closed at $26.05 per share.
-
How To Buy Sumitomo Osaka Cement Stock Online?
In order to purchase Sumitomo Osaka Cement stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 49.62% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is up 10.88% over the past day.
